RNS Announcements

All the posts published.

PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine

Dec 21, 2020
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine Versamune® T-cell activating platform demonstrates breadth of anti-SARS-CoV-2 immune responses in a COVID-19 vaccine   London, UK – 21 December 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, [...]

ProAxsis Limited awarded Innovate UK grant to utilise company technology to identify high risk COVID-19 patients

Dec 10, 2020
-
News, ProAxsis, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited awarded Innovate UK grant to utilise company technology to identify high risk COVID-19 patients London, UK - 10 December 2020 - NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, announces that its portfolio company ProAxsis Limited ("ProAxsis"), announced that it has been awarded [...]

Board changes and grant of Options

Dec 2, 2020
-
News, RNS Announcements
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Board changes and grant of Options   London, UK – 2 December 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation Group, is pleased to announce the planned strengthening of the Board in line with the stated strategy and shareholder circular from 6 [...]

NetScientific’s EMV Capital Ltd leads a £1.28m pre-Series A round in SageTech Medical Equipment Ltd to commercialise its anaesthetic gas recycling technology platform

Nov 30, 2020
-
EMV, News, RNS Announcements
NetScientific plc (“NetScientific” or the “Company”)   NetScientific’s EMV Capital Ltd leads a £1.28m pre-Series A round in SageTech Medical Equipment Ltd to commercialise its anaesthetic gas recycling technology platform   London, UK – 30 November 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation Group, announces that its subsidiary EMV [...]

ProAxsis Limited appoints DiaPharma as distributor to key North America region

Nov 19, 2020
-
News, ProAxsis, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited appoints DiaPharma as distributor to key North America region London, UK – 19 November 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology investment and commercialisation company, announces that its portfolio company ProAxsis Limited ("ProAxsis"), today announced that it has appointed DiaPharma Group Inc. (“DiaPharma”) as the [...]

PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine

Nov 11, 2020
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine PDS0203 prioritized for clinical development by PDS Biotech and Farmacore after successful meeting with Brazilian Drug Regulatory Agency London, UK – 11 November 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology investment and commercialisation company, announces [...]

PDS Biotech launch Merck Trials

Nov 10, 2020
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific" or the "Company")   PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck VERSATILE-002 Trial for First Line Treatment of Recurrent/Metastatic Head and Neck Cancer with Combination PDS0101-KEYTRUDA® is Now Open and Recruiting Patients London, UK – 09 November 2020 – NetScientific [...]

PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101

Oct 27, 2020
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 in Combination with Standard of Care Chemoradiotherapy in Advanced Cervical Cancer London, UK – 26 October 2020 – NetScientific plc (AIM: NSCI), the life sciences and technology investment and commercialisation company, announces that it its portfolio company PDS Biotechnology Corporation ("PDS") [...]

NetScientific acquires 100% control of portfolio company ProAxsis Limited

Oct 19, 2020
-
News, ProAxsis, RNS Announcements
NetScientific plc ("NetScientific" or the "Company")   NetScientific plc   NetScientific acquires 100% control of portfolio company ProAxsis Limited London, UK – 16 October 2020 – NetScientific plc (AIM:NSCI), the life sciences and technology investment and commercialisation company, announces that it has agreed to acquire the outstanding minority interest of 43.6% of its portfolio company, ProAxsis Limited (“ProAxsis”) [...]

Grant of Options to Director

Sep 25, 2020
-
News, RNS Announcements
NetScientific plc ("NetScientific" or the "Company")   Grant of Options to Director London, UK – 25 September 2020 – NetScientific plc (AIM:NSCI) (the "Company"), the life sciences and technology Group, announces that on 25 September 2020 it granted 382,465 options over ordinary shares of 5p each to its chief executive officer Dr Ilian Iliev (the "New Options").   [...]
RNS Announcements Archives - NetScientific